{"id":"sterile-0-9-sodium-chloride","safety":{"commonSideEffects":[{"rate":null,"effect":"Hypersensitivity reactions"},{"rate":null,"effect":"Infection"},{"rate":null,"effect":"Hypotension"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"It works by increasing the concentration of sodium ions in the blood, which helps to regulate the amount of water in the body and maintain proper blood pressure. This can be especially important for patients who are experiencing dehydration or have conditions that affect fluid balance.","oneSentence":"Sodium chloride is an electrolyte replenisher that helps maintain fluid balance and blood pressure.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:36:36.360Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Fluid replacement and maintenance"},{"name":"Prevention of dehydration"}]},"trialDetails":[{"nctId":"NCT07498660","phase":"NA","title":"PRP Injection Into the Sacroiliac Joint After Ipsilateral THA: Effects on Early Recovery and Function (SIJ-THA Randomized Trial)","status":"NOT_YET_RECRUITING","sponsor":"Medical University of Warsaw","startDate":"2026-04-01","conditions":"Osteoarthitis, Sacro Iliac Joint Pain, Hip Arthroplasty, Total","enrollment":60},{"nctId":"NCT07491302","phase":"PHASE2","title":"Thumb Base Osteoarthritis: Ultrasound-guided Platelet-rich Plasma Versus Placebo Injection","status":"NOT_YET_RECRUITING","sponsor":"Goed Medisch Centrum","startDate":"2026-03","conditions":"Thumb Osteoarthritis","enrollment":88},{"nctId":"NCT05652504","phase":"PHASE1","title":"Safety Evaluation of PfSPZ Vaccine in Pregnant Women in Mali (MalVIP1)","status":"SUSPENDED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2026-04-01","conditions":"Malaria","enrollment":400},{"nctId":"NCT07037771","phase":"PHASE3","title":"A Phase 3 Study of Zodasiran in Adolescent and Adult Subjects With Homozygous Familial Hypercholesterolemia (YOSEMITE)","status":"RECRUITING","sponsor":"Arrowhead Pharmaceuticals","startDate":"2025-06-17","conditions":"Homozygous Familial Hypercholesterolemia","enrollment":60},{"nctId":"NCT06033196","phase":"PHASE2","title":"Tocilizumab in Lung Transplantation","status":"RECRUITING","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2024-02-13","conditions":"Lung Transplant","enrollment":350},{"nctId":"NCT07490366","phase":"NA","title":"Comparison of the Effectiveness of Exercise, Dry Needling and Interfascial Block Treatments in the Treatment of Myofascial Pain Syndrome","status":"RECRUITING","sponsor":"Eren Başıbüyük","startDate":"2025-08-01","conditions":"Myofascial Pain of Upper Trapezius Muscle","enrollment":78},{"nctId":"NCT07486544","phase":"PHASE3","title":"Soaked Pharyngeal Packing Agents in Septoplasty","status":"RECRUITING","sponsor":"Assiut University","startDate":"2026-03-20","conditions":"Sore Throat","enrollment":90},{"nctId":"NCT07437339","phase":"PHASE4","title":"Volume Reduction for Open Fracture Irrigation","status":"NOT_YET_RECRUITING","sponsor":"Inova Health Care Services","startDate":"2026-02-27","conditions":"Open Fracture","enrollment":200},{"nctId":"NCT07489430","phase":"PHASE2","title":"DaxibotulinumtoxinA for Blepharospasm","status":"NOT_YET_RECRUITING","sponsor":"University of Pennsylvania","startDate":"2026-07-01","conditions":"Blepharospasm of Both Eyelids, Blepharospasm of Left Eyelid, Blepharospasm of Right Eyelid","enrollment":20},{"nctId":"NCT06209177","phase":"PHASE1","title":"Study of ARO-CFB in Adult Healthy Volunteers","status":"ACTIVE_NOT_RECRUITING","sponsor":"Arrowhead Pharmaceuticals","startDate":"2024-04-05","conditions":"IgA Nephropathy","enrollment":49},{"nctId":"NCT05610800","phase":"PHASE2","title":"Exenatide for Smoking Cessation and Prevention of Weight Gain","status":"COMPLETED","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2022-12-07","conditions":"Smoking Cessation, Weight Gain","enrollment":140},{"nctId":"NCT05992935","phase":"PHASE1, PHASE2","title":"Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1403 and mRNA-1405 to Prevent Norovirus Acute Gastroenteritis in Healthy Adults 18 to 80 Years of Age","status":"RECRUITING","sponsor":"ModernaTX, Inc.","startDate":"2023-08-25","conditions":"Norovirus Acute Gastroenteritis","enrollment":1405},{"nctId":"NCT07488988","phase":"PHASE2","title":"SCARFREE-001: Verteporfin for Scar Prevention","status":"NOT_YET_RECRUITING","sponsor":"Odense University Hospital","startDate":"2026-06","conditions":"Surgical Scar","enrollment":12},{"nctId":"NCT05996835","phase":"PHASE2","title":"Phase 2b Study to Investigate the Safety and Efficacy of TIN816 in Sepsis-associated Acute Kidney Injury (CLEAR-AKI)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Novartis Pharmaceuticals","startDate":"2024-01-18","conditions":"Acute Kidney Injury Due to Sepsis","enrollment":320},{"nctId":"NCT04901169","phase":"PHASE2, PHASE3","title":"Angiotensin II in Liver Transplantation","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of California, San Francisco","startDate":"2022-06-28","conditions":"Liver Transplant; Complications, Vasoplegia","enrollment":50},{"nctId":"NCT07482423","phase":"PHASE1, PHASE2","title":"XVIE to Treat Androgenetic Alopecia (AGA)","status":"NOT_YET_RECRUITING","sponsor":"Restore Biologics Holdings, Inc. dba Xtressé","startDate":"2026-05-01","conditions":"Androgenetic Alopecia","enrollment":30},{"nctId":"NCT06451120","phase":"PHASE2","title":"Platelet Rich Plasma Injections In Young And Old Human Subjects","status":"RECRUITING","sponsor":"University of California, San Francisco","startDate":"2024-06-01","conditions":"Osteoarthritis, Articular Cartilage, Musculoskeletal Disorders","enrollment":60},{"nctId":"NCT07048314","phase":"PHASE1, PHASE2","title":"Stem Cells for Erectile Dysfunction Post RALP","status":"NOT_YET_RECRUITING","sponsor":"The Methodist Hospital Research Institute","startDate":"2026-03-10","conditions":"Erectile Dysfunction, Prostate Cancer","enrollment":40},{"nctId":"NCT07481539","phase":"PHASE2","title":"Subcutaneous Piperacillin/Tazobactam Compared With Intravenous Treatment","status":"RECRUITING","sponsor":"Azienda Sanitaria Universitaria Friuli Centrale","startDate":"2026-03-24","conditions":"Bacteria Infection, Piperacillin, Tazobactam Drug Combination","enrollment":240},{"nctId":"NCT07227948","phase":"PHASE2","title":"Repurposing Semaglutide for the Treatment of Cocaine Use Disorder","status":"RECRUITING","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2026-01-15","conditions":"Cocaine Use Disorder","enrollment":75},{"nctId":"NCT07480161","phase":"PHASE2, PHASE3","title":"Mesenchymal Stem Cell and Exosome Therapy for Diabetic Erectile Dysfunction","status":"RECRUITING","sponsor":"Ankara City Hospital Bilkent","startDate":"2025-12-29","conditions":"Erectile Dysfunction With Diabetes Mellitus","enrollment":90},{"nctId":"NCT06409156","phase":"NA","title":"EOIFP Block Versus OSTAP Block for Upper Abdominal Surgery","status":"RECRUITING","sponsor":"The Cleveland Clinic","startDate":"2024-06-26","conditions":"Open Abdominal Surgery","enrollment":100},{"nctId":"NCT07434024","phase":"NA","title":"Erector Spinae Plane Block for Acute Low Back Pain","status":"NOT_YET_RECRUITING","sponsor":"University Hospital, Montpellier","startDate":"2026-03","conditions":"Non-specific Low Back Pain (NSLBP)","enrollment":300},{"nctId":"NCT04512235","phase":"PHASE3","title":"A Study to Evaluate the Efficacy and Safety of CAEL-101 in Patients With Mayo Stage IIIa AL Amyloidosis (CARES)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Alexion Pharmaceuticals, Inc.","startDate":"2020-11-03","conditions":"AL Amyloidosis","enrollment":281},{"nctId":"NCT04504825","phase":"PHASE3","title":"A Study to Evaluate the Efficacy and Safety of CAEL-101 in Patients With Mayo Stage IIIb AL Amyloidosis (CARES)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Alexion Pharmaceuticals, Inc.","startDate":"2020-08-25","conditions":"AL Amyloidosis","enrollment":125},{"nctId":"NCT07473752","phase":"PHASE1","title":"A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of TNX-1500 in Healthy Subjects","status":"COMPLETED","sponsor":"Tonix Pharmaceuticals, Inc.","startDate":"2023-07-18","conditions":"Phase 1 First-in-human Study Involving Healthy Subjects","enrollment":26},{"nctId":"NCT06252623","phase":"PHASE1","title":"Exenatide For Reducing the Reinforcing Effects of Cocaine","status":"WITHDRAWN","sponsor":"Christopher D. Verrico","startDate":"2024-08-01","conditions":"Cocaine Use Disorder","enrollment":""},{"nctId":"NCT07266558","phase":"PHASE4","title":"A Study to Evaluate the Efficacy and Safety of mRNA-1283 and mRNA-1273 in Participants 50 to 64 Years of Age Without High-Risk Conditions for Severe Coronavirus Disease 2019 (COVID-19)","status":"RECRUITING","sponsor":"ModernaTX, Inc.","startDate":"2025-11-26","conditions":"SARS-CoV-2","enrollment":30000},{"nctId":"NCT05491356","phase":"PHASE4","title":"Use of Tissue Plasminogen Activator in the Clearance of Chronic Subdural Hematomas","status":"COMPLETED","sponsor":"Hamilton Health Sciences Corporation","startDate":"2023-05-11","conditions":"Hematoma, Subdural, Fibrinolytic; Hemorrhage","enrollment":40},{"nctId":"NCT06353529","phase":"PHASE4","title":"Postop Pain Management in Pituitary Tumour Patients","status":"RECRUITING","sponsor":"Hamilton Health Sciences Corporation","startDate":"2024-11-25","conditions":"Pituitary, Pain, Postoperative","enrollment":108},{"nctId":"NCT07386327","phase":"NA","title":"Impact of Bupivacaine Dilution With Dextrose or Saline on Infraclavicular Block Outcomes","status":"RECRUITING","sponsor":"Burçin Alaçam, MD","startDate":"2026-03-09","conditions":"Infraclavicular Brachial Plexus Block, Dextrose, Bupivacaine","enrollment":90},{"nctId":"NCT07464392","phase":"NA","title":"FMT for the Prevention of Infectious Complications in Patients With Moderately Severe and Severe Acute Pancreatitis","status":"NOT_YET_RECRUITING","sponsor":"Changhai Hospital","startDate":"2026-03-01","conditions":"Acute Pancreatitis","enrollment":150},{"nctId":"NCT06059846","phase":"PHASE3","title":"A Study of Oral Tebipenem Pivoxil Hydrobromide (TBP-PI-HBr) Compared to Intravenous Imipenem-cilastatin in Participants With Complicated Urinary Tract Infection (cUTI) or Acute Pyelonephritis (AP)","status":"COMPLETED","sponsor":"Spero Therapeutics","startDate":"2023-12-21","conditions":"Urinary Tract Infection, Acute Pyelonephritis","enrollment":1690},{"nctId":"NCT06028126","phase":"NA","title":"Superficial Parasternal Intercostal Plane Block in Cardiac Surgery Trial","status":"COMPLETED","sponsor":"Unity Health Toronto","startDate":"2023-09-08","conditions":"Post-operative Pain, Post-operative Delirium, Post-cardiac Surgery","enrollment":340},{"nctId":"NCT04102371","phase":"PHASE3","title":"Pragmatic Pediatric Trial of Balanced Versus Normal Saline Fluid in Sepsis","status":"COMPLETED","sponsor":"Children's Hospital of Philadelphia","startDate":"2020-08-25","conditions":"Shock, Septic","enrollment":9041},{"nctId":"NCT07448129","phase":"NA","title":"Clinical Trial to Evaluate the Efficacy and Safety of SUBMO® as a Submucosal Injection Agent in Endoscopic Resection of Superficial Gastrointestinal Lesions.","status":"NOT_YET_RECRUITING","sponsor":"i+Med S.Coop.","startDate":"2026-03","conditions":"Colorectal Polyps","enrollment":300},{"nctId":"NCT05677971","phase":"PHASE3","title":"Study to Check the Safety of Fazirsiran and Learn if Fazirsiran Can Help People With Liver Disease and Scarring (Fibrosis) Due to an Abnormal Version of Alpha-1 Antitrypsin Protein","status":"RECRUITING","sponsor":"Takeda","startDate":"2023-03-06","conditions":"Alpha1-Antitrypsin Deficiency","enrollment":160},{"nctId":"NCT07449572","phase":"PHASE1","title":"Clinical Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of HT31-1 for Treating ARDS","status":"NOT_YET_RECRUITING","sponsor":"HTIC, Inc","startDate":"2026-03","conditions":"ARDS (Acute Respiratory Distress Syndrome)","enrollment":24},{"nctId":"NCT07448246","phase":"NA","title":"Effect of Bilateral Rhomboid Intercostal Block on Postoperative Pain After Breast Implant Surgery","status":"RECRUITING","sponsor":"Aydin Adnan Menderes University","startDate":"2026-02-15","conditions":"Breast Prosthesis; Pain, Postoperative Pain, Breast Augmentation","enrollment":40},{"nctId":"NCT03644667","phase":"PHASE2","title":"Tocilizumab in Cardiac Transplantation","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2018-12-20","conditions":"Heart Transplant","enrollment":385},{"nctId":"NCT06529159","phase":"NA","title":"H. Pylori Eradication With Argon Plasma During Endoscopy","status":"RECRUITING","sponsor":"Christopher C. Thompson, MD, MSc","startDate":"2025-07-08","conditions":"Helicobacter Pylori Infection, Helicobacter Pylori, Helicobacter Pylori Gastrointestinal Tract Infection","enrollment":20},{"nctId":"NCT07022977","phase":"PHASE1, PHASE2","title":"A Study of MET233 in Individuals With Obesity or Overweight","status":"ACTIVE_NOT_RECRUITING","sponsor":"Metsera, a wholly owned subsidiary of Pfizer","startDate":"2024-11-20","conditions":"Obesity and Overweight","enrollment":120},{"nctId":"NCT07440173","phase":"PHASE4","title":"Phenol and Botulinum Toxin vs Botulinum Toxin Alone for Post-Stroke Upper-Limb Spasticity","status":"NOT_YET_RECRUITING","sponsor":"Assiut University","startDate":"2026-05-01","conditions":"Spasticity as Sequela of Stroke","enrollment":60},{"nctId":"NCT06924853","phase":"NA","title":"Platelet Lysate vs Saline for Lumbosacral Radiculopathy","status":"TERMINATED","sponsor":"Regenexx, LLC","startDate":"2025-07-01","conditions":"Lumbosacral Radiculopathy, Lumbar Radiculopathy","enrollment":2},{"nctId":"NCT07432581","phase":"NA","title":"Topical Insulin Dressing on Management of Diabetic Foot Ulcers","status":"COMPLETED","sponsor":"Cairo University","startDate":"2023-01-01","conditions":"Topical, Insulin, Dressing","enrollment":30},{"nctId":"NCT05279768","phase":"PHASE1, PHASE2","title":"Stem Cells and Secretomes for Infertility Therapy in Polycystic Ovary Syndrome (PCOS) Patients With Insulin Resistance.","status":"COMPLETED","sponsor":"PT. Prodia Stem Cell Indonesia","startDate":"2022-09-01","conditions":"Polycystic Ovary Syndrome","enrollment":44},{"nctId":"NCT07429019","phase":"NA","title":"Intraoperative Bupivacaine Injection to Reduce Acute and Chronic Pain After TVT/TVT-O Surgery. Randomized Double-Blind Trial","status":"NOT_YET_RECRUITING","sponsor":"Hadassah Medical Organization","startDate":"2026-03-01","conditions":"Pain After Surgery, PSP, Chronic Pain Syndrome","enrollment":60},{"nctId":"NCT04998201","phase":"PHASE2","title":"Study of Plozasiran (ARO-APOC3) in Adults With Mixed Dyslipidemia","status":"COMPLETED","sponsor":"Arrowhead Pharmaceuticals","startDate":"2021-09-28","conditions":"Mixed Dyslipidemia","enrollment":353},{"nctId":"NCT06488794","phase":"PHASE2, PHASE3","title":"Nebulised Colistimethate Sodium to Prevent Pediatric Ventilator-associated Pneumonia","status":"NOT_YET_RECRUITING","sponsor":"University Hospital Fattouma Bourguiba","startDate":"2027-01-01","conditions":"Ventilator Associated Pneumonia","enrollment":400},{"nctId":"NCT06080243","phase":"PHASE2","title":"Assessment of Safety, Immunogenicity and Efficacy of R21/Matrix-M1 Malaria Vaccine in Healthy WOCBP in Mali","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Oxford","startDate":"2025-03-19","conditions":"Healthy Women of Child Bearing Potential","enrollment":330},{"nctId":"NCT07426172","phase":"NA","title":"Role of Elevated Lactate Levels on Lipid and Carbohydrate Metabolism.","status":"RECRUITING","sponsor":"Ricardo Mora","startDate":"2026-01-20","conditions":"Hyperlactatemia, Metabolic Syndrome (MetS), Lipolysis","enrollment":24},{"nctId":"NCT06476925","phase":"NA","title":"Role of Left Stellate Ganglion Block in Offering Myocardial Protection in On-pump Mitral Valve Replacement? A Histopathological and Clinical Assessment","status":"COMPLETED","sponsor":"Minia University","startDate":"2024-07-15","conditions":"Open Mitral Cardiac Surgery","enrollment":62},{"nctId":"NCT06597006","phase":"PHASE3","title":"Study to Evaluate Safety, Tolerability and Efficacy of Inclisiran in Children With Homozygous Familial Hypercholesterolemia","status":"RECRUITING","sponsor":"Novartis Pharmaceuticals","startDate":"2025-02-28","conditions":"Familial Hypercholesterolemia - Homozygous","enrollment":9},{"nctId":"NCT05174507","phase":"PHASE2","title":"Empagliflozin and Anakinra for the Treatment of Postprandial Hypoglycemia in Patients With Prediabetes","status":"WITHDRAWN","sponsor":"University Hospital, Basel, Switzerland","startDate":"2022-06-24","conditions":"Postprandial Hypoglycemia","enrollment":""},{"nctId":"NCT07385287","phase":"PHASE2","title":"Field Trial of PfSPZ-LARC2 Vaccine in Burkinabe Adults","status":"NOT_YET_RECRUITING","sponsor":"Sanaria Inc.","startDate":"2026-04-04","conditions":"Malaria (Plasmodium Falciparum)","enrollment":180},{"nctId":"NCT03929601","phase":"PHASE2","title":"Rituximab-pvvr and Abatacept vs Rituximab-pvvr Alone in New Onset Type 1 Diabetes","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","startDate":"2023-10-30","conditions":"Type 1 Diabetes Mellitus","enrollment":74},{"nctId":"NCT07413055","phase":"PHASE3","title":"Dexamethasone (4 mg vs. 8 mg) for Pain Control in Dental Implant Surgery","status":"RECRUITING","sponsor":"Oman Ministry of Health","startDate":"2026-02-05","conditions":"Postoperative Pain","enrollment":138},{"nctId":"NCT05591339","phase":"PHASE4","title":"Diabetes Diagnosis, Management, Prevention and Education in Guinea-Bissau","status":"ACTIVE_NOT_RECRUITING","sponsor":"Bandim Health Project","startDate":"2023-12-01","conditions":"Diabetes Mellitus, BCG Vaccination Reaction","enrollment":200},{"nctId":"NCT07052903","phase":"PHASE3","title":"TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy","status":"RECRUITING","sponsor":"Alnylam Pharmaceuticals","startDate":"2025-07-02","conditions":"Transthyretin Amyloidosis With Cardiomyopathy","enrollment":1250},{"nctId":"NCT07412080","phase":"PHASE1","title":"EDP167 in Healthy Volunteers and Subjects With Mild Dyslipidemia","status":"COMPLETED","sponsor":"Eddingpharm (Zhuhai) Co., Ltd.","startDate":"2025-07-01","conditions":"Healthy Adult Male and Female Volunteers, Mild Dyslipidemia","enrollment":40},{"nctId":"NCT06897202","phase":"PHASE2","title":"A Study to Evaluate the Efficacy and Safety of Once-Weekly MET097 in Adults With Obesity or Overweight and T2DM","status":"ACTIVE_NOT_RECRUITING","sponsor":"Metsera, a wholly owned subsidiary of Pfizer","startDate":"2025-03-14","conditions":"Obesity in Diabetes, Type 2 Diabetes Mellitus (T2DM)","enrollment":133},{"nctId":"NCT07363135","phase":"NA","title":"Evaluation of Albumin Platelet-Rich Fibrin Following SRP in Patients With Periodontitis","status":"COMPLETED","sponsor":"Saglik Bilimleri Universitesi","startDate":"2024-11-20","conditions":"Periodontitis, Periodontitis (Stage 3)","enrollment":23},{"nctId":"NCT06712836","phase":"PHASE2","title":"A Phase 2b Study to Examine the Safety and Efficacy of Once-Weekly MET097 in Adults With Obesity or Overweight","status":"ACTIVE_NOT_RECRUITING","sponsor":"Metsera, a wholly owned subsidiary of Pfizer","startDate":"2024-10-24","conditions":"Obesity, Overweight or Obesity","enrollment":225},{"nctId":"NCT06973720","phase":"PHASE2","title":"A Phase 2b Study to Evaluate the Efficacy and Safety of Once-Monthly MET097 in Adults With Obesity or Overweight","status":"ACTIVE_NOT_RECRUITING","sponsor":"Metsera, a wholly owned subsidiary of Pfizer","startDate":"2025-04-01","conditions":"Obesity, Overweight or Obesity","enrollment":250},{"nctId":"NCT06780306","phase":"PHASE2","title":"A Study in the Treatment of Mild to Moderate Dry Eye Disease Comparing Saline to TTAX03.","status":"COMPLETED","sponsor":"BioTissue Holdings, Inc","startDate":"2024-12-12","conditions":"Dry Eye, Dry Eye Disease (DED), Dry Eye Disease With Severe Keratitis","enrollment":74},{"nctId":"NCT07398612","phase":"PHASE1, PHASE2","title":"Safety and Efficacy of Human Adipose-Derived Stem Cell Exosomes in Acute Ischemic Stroke","status":"NOT_YET_RECRUITING","sponsor":"Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine","startDate":"2026-01-31","conditions":"Acute Ischemic Stroke","enrollment":60},{"nctId":"NCT06287619","phase":"PHASE2","title":"Post-operative Intravenous Iron to Treat Iron-deficiency Anemia in Patients Undergoing Cardiac Surgery","status":"RECRUITING","sponsor":"University Health Network, Toronto","startDate":"2025-04-03","conditions":"Chronic Iron Deficiency Anaemia, Cardiac Surgery","enrollment":60},{"nctId":"NCT02743455","phase":"PHASE1","title":"A Trial to Evaluate the Safety, Reactogenicity, and Immunogenicity of MVA-BN Yellow Fever Vaccine With and Without Montanide ISA-720 Adjuvant in 18-45 Year Old Healthy Volunteers","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2016-07-05","conditions":"Yellow Fever, Yellow Fever Immunisation","enrollment":92},{"nctId":"NCT07374562","phase":"NA","title":"Stellate Ganglion Block for Long COVID Symptoms: A Randomized Controlled Trial","status":"RECRUITING","sponsor":"Centre intégré universitaire de santé et de services sociaux de la Mauricie-et-du-Centre-du-Québec","startDate":"2026-02-05","conditions":"Long COVID","enrollment":40},{"nctId":"NCT07392697","phase":"NA","title":"The Intravenous Amino Acid Therapy for Vascular Rigidity in End Stage Renal Disease","status":"NOT_YET_RECRUITING","sponsor":"Haukeland University Hospital","startDate":"2026-02-01","conditions":"Chronic Kidney Disease Requiring Chronic Dialysis, Cardiovascular Calcification","enrollment":120},{"nctId":"NCT06880770","phase":"PHASE3","title":"Study of Plozasiran in Adults With Severe Hypertriglyceridemia at Risk of Acute Pancreatitis","status":"RECRUITING","sponsor":"Arrowhead Pharmaceuticals","startDate":"2025-04-24","conditions":"Severe Hypertriglyceridemia","enrollment":288},{"nctId":"NCT04918147","phase":"PHASE2","title":"Elotuzumab in Immunoglobulin G4-Related Disease (IgG4-RD)","status":"TERMINATED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2021-10-13","conditions":"IgG4 Related Disease, IgG4-RD","enrollment":8},{"nctId":"NCT06143046","phase":"PHASE2","title":"A Study of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus in Pregnant Women and in Infants Born to Vaccinated Mothers","status":"ACTIVE_NOT_RECRUITING","sponsor":"ModernaTX, Inc.","startDate":"2023-11-15","conditions":"Respiratory Syncytial Virus","enrollment":360},{"nctId":"NCT05089084","phase":"PHASE3","title":"Study of ARO-APOC3 (Plozasiran) in Adults With Familial Chylomicronemia Syndrome (FCS)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Arrowhead Pharmaceuticals","startDate":"2021-12-14","conditions":"Familial Chylomicronemia","enrollment":75},{"nctId":"NCT07386938","phase":"PHASE3","title":"A Study of the Efficacy, Safety and Pharmacokinetics of RPH-051 and Perjeta® in Combination With Trastuzumab and Docetaxel as the 1st Line Therapy in Patients With HER2-positive Breast Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"R-Pharm","startDate":"2024-08-09","conditions":"Locally Advanced Breast Cancer, Metastatic Breast Cancer","enrollment":246},{"nctId":"NCT06924320","phase":"PHASE1, PHASE2","title":"A Study of MET233 in Combination With MET097 in Individuals With Obesity or Overweight With or Without Diabetes","status":"RECRUITING","sponsor":"Metsera, a wholly owned subsidiary of Pfizer","startDate":"2025-03-03","conditions":"Obesity and Obesity-related Medical Conditions","enrollment":132},{"nctId":"NCT07352800","phase":"PHASE2","title":"Safety of Antithrombotic Heparin Proteoglycan Mimetic APAC in Peripheral Arterial Occlusive Disease and Chronic Limb-threatening Ischemia","status":"RECRUITING","sponsor":"Aplagon Oy","startDate":"2026-01-29","conditions":"Peripheral Arterial Occlusive Disease, Chronic Limb-Threatening Ischemia","enrollment":42},{"nctId":"NCT05500417","phase":"PHASE1","title":"Safety and Immunogenicity of CJCV2 With and Without ALFQ","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2022-09-13","conditions":"Campylobacter Infection","enrollment":59},{"nctId":"NCT05856890","phase":"PHASE1","title":"HepB mAb19 in Individuals With Chronic Hepatitis B Infection","status":"RECRUITING","sponsor":"Rockefeller University","startDate":"2023-08-07","conditions":"Hepatitis b Virus, Hepatitis B","enrollment":37},{"nctId":"NCT07229118","phase":"PHASE1","title":"A Study to Evaluate COR-1004 in Adult Volunteers.","status":"RECRUITING","sponsor":"Corsera Health","startDate":"2025-11-28","conditions":"Hyperlipidemia","enrollment":60},{"nctId":"NCT06366087","phase":"PHASE1","title":"Sublingual Atropine Bioequivalence by Route of Administration (SABER)","status":"COMPLETED","sponsor":"Biomedical Advanced Research and Development Authority","startDate":"2024-04-15","conditions":"Atropine Bioequivalence","enrollment":46},{"nctId":"NCT07011303","phase":"NA","title":"Investigation of the Effect of Horizontal Platelet Rich Fibrin Placed in Tooth Extraction Sockets on Bone Formation","status":"ENROLLING_BY_INVITATION","sponsor":"Tokat Gaziosmanpasa University","startDate":"2024-06-01","conditions":"Tooth Loss, Dental Implant Failed, Alveolar Bone Loss","enrollment":30},{"nctId":"NCT06572267","phase":"PHASE2","title":"Safety and Efficacy of Meplazumab in Patients With Coronary Artery Disease","status":"RECRUITING","sponsor":"Xijing Hospital","startDate":"2024-10-16","conditions":"Coronary Artery Disease","enrollment":18},{"nctId":"NCT07362992","phase":"EARLY_PHASE1","title":"Topical Tranexamic Acid to Reduce Blood Loss During Cesarean Delivery","status":"NOT_YET_RECRUITING","sponsor":"Wolfson Medical Center","startDate":"2026-01-01","conditions":"Cesarean Delivery, Postpartum Hemorrhage (PPH), Intraoperative Blood Loss","enrollment":112},{"nctId":"NCT07360483","phase":"NA","title":"Treatment of Hypertrophic Scars Using Fractional CO2 Laser Alone in Comparison With Adding Botulinum Toxin Either Through Intralesional Injection or Assisted Drug Delivery","status":"COMPLETED","sponsor":"Cairo University","startDate":"2025-01-01","conditions":"Hypertrophic Scars","enrollment":48},{"nctId":"NCT07359560","phase":"NA","title":"Lidocaine vs Magnesium Sulfate for Hemodynamic Stability During Emergence in Infertility-Related Laparoscopic Surgery\"","status":"NOT_YET_RECRUITING","sponsor":"Zagazig University","startDate":"2026-01-02","conditions":"Infertility Female, Hemodynamic Instability","enrollment":69},{"nctId":"NCT07152600","phase":"PHASE3","title":"Adaptive RCT of Corticosteroids for Severe Adenovirus Pneumonia in Adults","status":"NOT_YET_RECRUITING","sponsor":"Qingyuan Zhan","startDate":"2026-02-01","conditions":"Adenovirus Infections, Human","enrollment":262},{"nctId":"NCT06495307","phase":"PHASE1, PHASE2","title":"RHPRG4 FOR THE TREATMENT OF OCULAR GRAFT-VERSUS-HOST DISEASE (OGVHD)","status":"TERMINATED","sponsor":"Lubris Bio Pty Ltd","startDate":"2025-02-14","conditions":"Ocular Graft-versus-host Disease","enrollment":3},{"nctId":"NCT05324358","phase":"PHASE3","title":"Ketorolac Applied by Continuous IV Infusion for Treatment of Moderately Severe Postoperative Pain Following Bunionectomy","status":"COMPLETED","sponsor":"Neumentum, Inc.","startDate":"2022-12-14","conditions":"Pain, Postoperative","enrollment":341},{"nctId":"NCT07352865","phase":"PHASE3","title":"Adaptive RCT of Corticosteroids for Severe Chlamydia Psittaci Pneumonia in Adults","status":"NOT_YET_RECRUITING","sponsor":"Qingyuan Zhan","startDate":"2026-01-15","conditions":"Psittacosis","enrollment":100},{"nctId":"NCT07351500","phase":"PHASE3","title":"Adaptive RCT of Corticosteroids for Severe Influenza Pneumonia in Adults","status":"NOT_YET_RECRUITING","sponsor":"Qingyuan Zhan","startDate":"2026-01-15","conditions":"Influenza","enrollment":496},{"nctId":"NCT06143059","phase":"PHASE3","title":"The Effects of Sex Hormones and Alcohol on Sleep","status":"SUSPENDED","sponsor":"Lauren Whitehurst","startDate":"2024-01-08","conditions":"Alcohol Use Disorder","enrollment":130},{"nctId":"NCT06305182","phase":"PHASE2","title":"Metreleptin in Anorexia Nervosa","status":"RECRUITING","sponsor":"Gabriella Milos","startDate":"2024-05-31","conditions":"Anorexia Nervosa","enrollment":50},{"nctId":"NCT05002998","phase":"PHASE4","title":"TEPEZZA® (Teprotumumab-trbw) Post-Marketing Requirement Study","status":"COMPLETED","sponsor":"Amgen","startDate":"2021-09-16","conditions":"Thyroid Eye Disease","enrollment":313},{"nctId":"NCT07343323","phase":"PHASE1","title":"A First-in-Human Study of KINE-101 in Healthy Volunteers","status":"COMPLETED","sponsor":"Kine Sciences Co., Ltd.","startDate":"2021-11-05","conditions":"Healthy Volunteers","enrollment":40},{"nctId":"NCT07223229","phase":"PHASE2","title":"Phase 2 Study to Evaluate EI-001 in Non-segmental Vitiligo Patients","status":"RECRUITING","sponsor":"Elixiron Immunotherapeutics (Hong Kong) Ltd.","startDate":"2025-12-30","conditions":"Non-segmental Vitiligo","enrollment":45},{"nctId":"NCT05845398","phase":"PHASE1","title":"Phase 1b Study of DCR-AUD in Healthy Volunteers","status":"COMPLETED","sponsor":"Dicerna Pharmaceuticals, Inc., a Novo Nordisk company","startDate":"2023-01-29","conditions":"Alcohol Use Disorder","enrollment":16},{"nctId":"NCT05947955","phase":"PHASE2","title":"Rhu-pGSN for Acute Respiratory Distress Syndrome (ARDS)","status":"RECRUITING","sponsor":"BioAegis Therapeutics Inc.","startDate":"2024-10-03","conditions":"Acute Respiratory Distress Syndrome, Infections","enrollment":600},{"nctId":"NCT04659863","phase":"PHASE3","title":"Study to Evaluate Efficacy and Safety of Inclisiran in Adolescents With Homozygous Familial Hypercholesterolemia","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2021-02-16","conditions":"Familial Hypercholesterolemia - Homozygous","enrollment":13},{"nctId":"NCT04652726","phase":"PHASE3","title":"Study to Evaluate Efficacy and Safety of Inclisiran in Adolescents With Heterozygous Familial Hypercholesterolemia","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2021-01-27","conditions":"Familial Hypercholesterolemia - Heterozygous","enrollment":141}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":17,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Sterile 0.9% Sodium Chloride","genericName":"Sterile 0.9% Sodium Chloride","companyName":"Hospital Clinico Universitario de Santiago","companyId":"hospital-clinico-universitario-de-santiago","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Sodium chloride is an electrolyte replenisher that helps maintain fluid balance and blood pressure. Used for Fluid replacement and maintenance, Prevention of dehydration.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}